Literature DB >> 21888874

Inducible and repressable oncogene-addicted hepatocellular carcinoma in Tet-on xmrk transgenic zebrafish.

Zhen Li1, Xiaoqian Huang, Huiqing Zhan, Zhiqiang Zeng, Caixia Li, Jan M Spitsbergen, Svenja Meierjohann, Manfred Schartl, Zhiyuan Gong.   

Abstract

BACKGROUND & AIMS: Liver cancer, mainly hepatocellular carcinoma, is a major malignancy and currently there are no effective treatment protocols due to insufficient understanding of hepatocarcinogenesis. As a potentially high-throughput and cost-effective experimental model, the zebrafish is increasingly recognized for disease studies. Here, we aim at using the zebrafish to generate a convenient hepatocellular carcinoma model.
METHODS: Using the Tet-on system for liver-specific expression of fish oncogene xmrk, a hyperactive version of epidermal growth factor receptor homolog, we have generated transgenic zebrafish with inducible development of liver cancer.
RESULTS: Liver tumors were rapidly induced with 100% penetrance in both juvenile and adult xmrk transgenic fish. Histological examination indicated that they all showed features of hepatocellular carcinoma. The induced liver tumors regressed rapidly upon inducer withdrawal. During the tumor induction stage, we detected increased cell proliferation and activation of Xmrk downstream targets Erk and Stat5, which were important for liver tumorigenesis as proved by inhibition experiments. When tumors regressed, there were decreased phosphorylated Erk and Stat5 accompanied with an increase in apoptosis.
CONCLUSIONS: Our zebrafish model demonstrates the potential of a hyperactivated epidermal growth factor receptor pathway in initiating heptocarcinogenesis. It provides clear evidence for the requirement of only a single oncogene for HCC initiation and maintenance and is thus a convenient model for further investigation of oncogene addiction and future anti-cancer drug screening.
Copyright © 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21888874     DOI: 10.1016/j.jhep.2011.07.025

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  55 in total

Review 1.  Zebrafish models of human liver development and disease.

Authors:  Benjamin J Wilkins; Michael Pack
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

2.  Inhibition of endogenous MTF-1 signaling in zebrafish embryos identifies novel roles for MTF-1 in development.

Authors:  Britton O'Shields; Andrew G McArthur; Andrew Holowiecki; Martin Kamper; Jeffrey Tapley; Matthew J Jenny
Journal:  Biochim Biophys Acta       Date:  2014-04-18

3.  Decaprenyl diphosphate synthase subunit 2 as a prognosis factor in hepatocellular carcinoma.

Authors:  Wei Huang; Fei Gao; Kang Li; Wen Wang; Ya-Rou Lai; Shao-Hui Tang; Dong-Hua Yang
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

4.  Rapid Analysis of Effects of Environmental Toxicants on Tumorigenesis and Inflammation Using a Transgenic Zebrafish Model for Liver Cancer.

Authors:  Qiqi Yang; Lyana Salim; Chuan Yan; Zhiyuan Gong
Journal:  Mar Biotechnol (NY)       Date:  2019-03-09       Impact factor: 3.619

Review 5.  Emergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterials.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Drug Discov Today       Date:  2012-08-10       Impact factor: 7.851

Review 6.  Zebrafish as a disease model for studying human hepatocellular carcinoma.

Authors:  Jeng-Wei Lu; Yi-Jung Ho; Yi-Ju Yang; Heng-An Liao; Shih-Ci Ciou; Liang-In Lin; Da-Liang Ou
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

7.  Transcriptional control analyses of the Xiphophorus melanoma oncogene.

Authors:  Janine Regneri; Jean-Nicolas Volff; Manfred Schartl
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2015-09-05       Impact factor: 3.228

Review 8.  Zebrafish cancer: the state of the art and the path forward.

Authors:  Richard White; Kristin Rose; Leonard Zon
Journal:  Nat Rev Cancer       Date:  2013-09       Impact factor: 60.716

Review 9.  Xmrks the Spot: Fish Models for Investigating Epidermal Growth Factor Receptor Signaling in Cancer Research.

Authors:  Jerry D Monroe; Faiza Basheer; Yann Gibert
Journal:  Cells       Date:  2021-05-07       Impact factor: 6.600

10.  A transgenic zebrafish liver tumor model with inducible Myc expression reveals conserved Myc signatures with mammalian liver tumors.

Authors:  Zhen Li; Weiling Zheng; Zhengyuan Wang; Zhiqiang Zeng; Huiqing Zhan; Caixia Li; Li Zhou; Chuan Yan; Jan M Spitsbergen; Zhiyuan Gong
Journal:  Dis Model Mech       Date:  2012-10-04       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.